Advanced Biomed Inc. (ADVB) Balance Sheet
ADVB balance sheet, FY2026
June 30, 2026 · U.S. dollars$13.8M assets = $1.5M liabilities + $12.3M equity
Both columns are drawn to the same scale: what ADVB owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ADVB financial health
Descriptive bands, not a rating. Fiscal FY2026.
ADVB balance sheet trends, FY2021–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $1.0MFY2021 | $13.8MFY2026 | +68.7%/yr | |
| Total liabilities | $30,131FY2021 | $1.5MFY2026 | +117.7%/yr | |
| Shareholders’ equity | $976,242FY2021 | $12.3MFY2026 | +65.9%/yr | |
| Cash & short-term investments | $65,922FY2021 | $385,535FY2026 | +42.4%/yr | |
| Total debt | $7,209FY2021 | $33,845FY2026 | +36.2%/yr | |
| Net cash (debt) | $58,713FY2021 | $351,690FY2026 | +$292,977 | |
| Working capital | $885,147FY2021 | $12.3MFY2026 | +$11.4M | |
| Book value per share | $0.90FY2021 | $9.80FY2026 | +61.1%/yr | |
| Current ratio | 32.22FY2021 | 9.33FY2026 | −22.89 | |
| Debt / equity | 0.01FY2021 | 0.00FY2026 | 0.00 | |
| Shares outstanding | 1.1MFY2021 | 1.3MFY2026 | +3.0%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ADVB assets
ADVB liabilities and equity
ADVB debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ADVB balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & short-term investments | $385,535 | $2.9M | $2.6M | $2.6M | $4.8M | $65,922 |
| Cash & equivalents | $385,535 | $2.9M | $2.6M | $2.6M | $4.8M | $65,922 |
| Receivables | $419,442 | $7,956 | $6,324 | $4,814 | $162,518 | $419 |
| Inventory | $0 | $0 | −$6,324 | $0 | $0 | $0 |
| Other current assets | $12.9M | $3.1M | $443,137 | $158,895 | $59,329 | $847,156 |
| Total current assets | $13.7M | $6.0M | $3.1M | $2.8M | $5.0M | $913,497 |
| Property, plant & equipment (net) | $0 | $65.4M | $651,269 | $954,070 | $1.2M | $92,876 |
| Goodwill & intangible assets | $0 | $0 | $118,998 | $250,321 | $410,799 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $1,204 | $0 | $638,870 | $609,598 | $71,021 | $0 |
| Total assets | $13.8M | $6.5M | $4.5M | $4.6M | $6.7M | $1.0M |
| Liabilities | ||||||
| Accounts payable | — | $21,658 | $620,476 | $632,820 | $762,202 | $194 |
| Short-term debt | $33,845 | $1.1M | $64,128 | $223,520 | $244,636 | $5,428 |
| Total current liabilities | $1.5M | $2.9M | $2.7M | $3.3M | $3.0M | $28,350 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | $126,740 | $235,373 | $468,868 | $7,021 |
| Other long-term liabilities | $0 | $145,651 | $64,529 | $18,806 | $232,191 | $1,781 |
| Total liabilities | $1.5M | $3.0M | $2.8M | $3.3M | $3.2M | $30,131 |
| Shareholders' equity | ||||||
| Common stock & paid-in capital | $1,652 | $21,640 | $20,000 | $20,000 | $99,000 | $14,721 |
| Retained earnings (deficit) | −$12.6M | −$19.2M | −$16.0M | −$13.2M | −$9.5M | −$5.4M |
| Accumulated other comprehensive income | $968,876 | $1.3M | $1.1M | $804,020 | $268,859 | −$177,086 |
| Total shareholders' equity | $12.3M | $3.5M | $1.7M | $1.3M | $3.5M | $976,242 |
| Key figures | ||||||
| Total debt | $33,845 | $1.3M | $128,657 | $242,326 | $476,827 | $7,209 |
| Net cash (debt) | $351,690 | $1.6M | $2.5M | $2.4M | $4.3M | $58,713 |
| Working capital | $12.3M | $3.1M | $318,650 | −$489,595 | $2.0M | $885,147 |
| Tangible book value | $12.3M | $3.5M | $1.5M | $1.1M | $3.1M | $976,242 |
| Book value per share | $9.80 | $3.21 | $1.54 | $1.21 | $3.23 | $0.90 |
| Shares outstanding | 1.3M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M |
| Current ratio | 9.33 | 2.09 | 1.12 | 0.85 | 1.67 | 32.22 |
| Quick ratio | 0.55 | 1.01 | 0.96 | 0.80 | 1.65 | 2.34 |
| Debt / equity | 0.00 | 0.36 | 0.08 | 0.19 | 0.14 | 0.01 |
| Equity / assets | 89.3% | 53.4% | 37.3% | 28.4% | 52.0% | 97.0% |
| Sep '26 | Mar '26 | Dec '25 | Sep '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & short-term investments | $385,535 | $2.6M | $82,897 | $87,161 | $156,135 | $2.7M | $2.6M | $2.6M | $2.6M | $2.8M | $2.6M |
| Cash & equivalents | $385,535 | $2.6M | $82,897 | $87,161 | $156,135 | $2.7M | $2.6M | $2.6M | $2.6M | $2.8M | $2.6M |
| Short-term investments | — | $9,992 | — | — | — | — | — | — | — | — | — |
| Receivables | $419,442 | $3,021 | $2,558 | $10,044 | $6,474 | $0 | $7,929 | $6,324 | $0 | $203,713 | $5,911 |
| Inventory | $0 | $8,835 | $9,069 | $9,296 | −$7,805 | $0 | $0 | −$6,324 | $0 | $0 | $0 |
| Other current assets | $12.9M | $7.9M | $247,022 | $85,248 | $7.6M | $481,656 | $477,815 | $443,137 | $443,137 | $215,042 | $188,179 |
| Total current assets | $13.7M | $10.5M | $341,546 | $191,749 | $7.7M | $3.1M | $3.1M | $3.1M | $3.1M | $3.2M | $2.8M |
| Property, plant & equipment (net) | $0 | $3,685 | $3,762 | $10,632 | $180,851 | $642,274 | $601,294 | $651,269 | $651,268 | $797,874 | $843,707 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $20,325 | $50,516 | $84,070 | $118,998 | $118,998 | $188,373 | $216,026 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $1,204 | $116,330 | $30 | $2,454 | $355,274 | $672,471 | $655,671 | $638,870 | $638,871 | $597,034 | $607,683 |
| Total assets | $13.8M | $10.6M | $345,338 | $204,835 | $8.3M | $4.5M | $4.5M | $4.5M | $4.5M | $4.8M | $4.4M |
| Liabilities | |||||||||||
| Accounts payable | — | $11,800 | $11,753 | $21,050 | $4.0M | $617,865 | $641,955 | $620,476 | $620,476 | $517,272 | $614,582 |
| Short-term debt | $33,845 | $701,626 | $19,661 | $77,411 | $142,524 | — | $1.3M | $64,128 | $62,211 | $130,101 | $185,105 |
| Total current liabilities | $1.5M | $1.4M | $39,896 | $99,906 | $4.1M | $3.8M | $3.3M | $2.7M | $2.7M | $4.6M | $3.6M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | $29,511 | $21,092 | $30,869 | $182,829 | $290,027 | $126,614 | $126,740 | — | $130,101 | $180,024 |
| Other long-term liabilities | $0 | $10,903 | $3,676 | $6,362 | $44,472 | $56,326 | $70,569 | $64,529 | $64,529 | $0 | $480 |
| Total liabilities | $1.5M | $1.4M | $43,572 | $106,268 | $4.2M | $3.9M | $3.4M | $2.8M | $2.8M | $4.6M | $3.6M |
| Shareholders' equity | |||||||||||
| Common stock & paid-in capital | $1,652 | $1,382 | $689 | $710 | $21,640 | — | $20,000 | $20,000 | $20,000 | $100,000 | $100,000 |
| Retained earnings (deficit) | −$12.6M | −$13.3M | −$406,168 | −$643,741 | −$18.5M | −$17.1M | −$16.2M | −$16.0M | −$16.0M | −$14.1M | −$14.0M |
| Accumulated other comprehensive income | $968,876 | $843,785 | $27,840 | $41,182 | $1.3M | — | $819,496 | $1.1M | $1.1M | $611,934 | $1.1M |
| Total shareholders' equity | $12.3M | $9.2M | $301,766 | $98,566 | $4.1M | $619,032 | $1.1M | $1.7M | $1.7M | $196,841 | $805,144 |
| Key figures | |||||||||||
| Total debt | $33,845 | $712,529 | $23,337 | $55,839 | $186,996 | — | $1.3M | $128,657 | $126,740 | $130,101 | $185,585 |
| Net cash (debt) | $351,690 | $1.9M | $59,560 | $31,322 | −$30,861 | — | $1.3M | $2.5M | $2.5M | $2.6M | $2.4M |
| Working capital | $12.3M | $9.1M | $301,650 | $91,843 | $3.6M | −$689,903 | −$176,636 | $318,650 | $318,650 | −$1.4M | −$861,792 |
| Tangible book value | $12.3M | $9.2M | $301,766 | $98,566 | $4.1M | $568,516 | $1.0M | $1.5M | $1.5M | $8,468 | $589,118 |
| Book value per share | $7.43 | $7.17 | $0.28 | $0.09 | $4.03 | $0.57 | $1.01 | $1.66 | $1.54 | $0.18 | $0.74 |
| Shares outstanding | 1.7M | 1.3M | 1.1M | 1.1M | 1.0M | 1.1M | 1.1M | 1.0M | 1.1M | 1.1M | 1.1M |
| Current ratio | 9.33 | 7.38 | 8.56 | 1.92 | 1.88 | 0.82 | 0.95 | 1.12 | 1.12 | 0.70 | 0.76 |
| Quick ratio | 0.55 | 1.83 | 2.14 | 0.97 | 0.04 | 0.69 | 0.80 | 0.96 | 0.95 | 0.65 | 0.71 |
| Debt / equity | 0.00 | 0.08 | 0.08 | 0.57 | 0.05 | — | 1.21 | 0.08 | 0.08 | 0.66 | 0.23 |
| Equity / assets | 89.3% | 86.5% | 87.4% | 48.1% | 49.8% | 13.7% | 24.4% | 37.3% | 37.3% | 4.1% | 18.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed October 13, 2026); data from EODHD.
ADVB financial position
At the end of fiscal 2026 (June 30, 2026), Advanced Biomed had total assets of $13.8 million (up 111.1% from a year earlier), total liabilities of $1.5 million and shareholders' equity of $12.3 million. It held $0.4 million in cash and short-term investments against $0.0 million of debt, a net cash position of $0.4 million. Its current ratio was 9.33. In the latest quarter (ended September 30, 2026) total assets were $13.8 million and equity $12.3 million.
Related: ADVB income statement, ADVB cash flow statement, ADVB key metrics. See the ADVB stock overview for the latest quote and news.
ADVB balance sheet FAQ
What are Advanced Biomed's total assets?
Advanced Biomed reported total assets of $13.8 million at the end of fiscal 2026 (June 30, 2026), compared with $6.5 million a year earlier.
How much debt does Advanced Biomed have?
Advanced Biomed had $0.0 million of total debt at the end of fiscal 2026, including short-term borrowings. Its debt-to-equity ratio was 0.00.
How much cash does Advanced Biomed have?
Advanced Biomed held $0.4 million in cash and short-term investments at the end of fiscal 2026; with $0.0 million of debt that is net cash of $0.4 million.
What is Advanced Biomed's book value?
Advanced Biomed's shareholders' equity (book value) was $12.3 million at the end of fiscal 2026, or $9.80 per share.
What is Advanced Biomed's current ratio?
Advanced Biomed had current assets of $13.7 million and current liabilities of $1.5 million, a current ratio of 9.33 (it can cover its short-term obligations).